Home > Development > Technology Transfer
■ Overseas technology transfer
| Product | Country | Current Status |
| Pramipexole SR | Europe + 30 countries in Central South America & the Middle East & Africa & Asia | Agreement signed & Technology transfer in progress |
| Galantamine SR | 20 countries including Spain, Portugal and Central & South America | Technology transfer completed |
| Pramipexole SR | Russia, Japan | Under negotiation |
| Levetiracetam IR | Indonesia |
| Levetiracetam SR | Russia |
| Galantamine SR | Russia |
| Ibandronate | Indonesia |
| Tamsulosin CR OD | Indonesia |
■ Domestic technology transfer
| Year | Classification | Product | Company |
| 2019 |
Antibacterial-Antifungal(OTC) |
Pharyngitis |
Hyundai Pharm |
| Anticonvulsant compound |
Lacosamide Syrup |
Hyundai Pharm |
| Antiallergic property |
Pemirolast Potassium Dry Syrup |
Hyundai Pharm |
| 2018 |
Treatment of Parkinson's disease |
Pramipexole SR |
Hyundai Pharm |
| Treatment of androgenic alopecia, |
Minoxyl External skin |
Hyundai Pharm |
| 2017 |
Anticonvulsant compound |
Lacosamide IR |
Hyundai Pharm |
| Treatment of Alzheimer’s disease |
Memantine HCl IR |
Hyundai Pharm |
| Antiallergic property |
Pemirolast Potassium |
Hyundai Pharm |
| 2016 |
Anticonvulsant compound |
Lacosamide CR |
Hyundai Pharm |
| 2012 |
Musculo-skeletal system Anticonvulsants |
Ibandronate |
15 companies including Ildong |
| Levetiracetam |
3 companies including Bukwang |
| 2011 |
Antipsychotics |
Olanzapine |
2 companies including Dongwha |
| Antilipemic agents |
Pitavastatin |
11 companies including Whanin |
| 2010 |
Antiviral agent |
Adefovir |
6 companies including JW pharm. |
| Lamivudine |
2 companies including Dongkoo |
| Angiotensin II receptor antagonists |
Olmesartan |
Kolon |
| Telmisartan |
Kolmar |
